Published in Women's Health Weekly, January 19th, 2006
Researchers in Austria conducted a study "to retrospectively determine the lesion miss rate and false-negative rate of NLOBB with stereotactic guidance in a large study population. The ethical review board approved the study; the need for informed consent was waived. A total of 1115 stereotactic NLOBBs performed in 1068 women aged 22-90 years (mean age, 54 years) were tracked to determine outcomes."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly